出版：MarketsandMarkets（マーケッツアンドマーケッツ） 出版年月：2024年3月
Minimally Invasive Surgery Market – Forecast to 2029
低侵襲手術市場 : 製品 [ロボット、イメージング、機器 (ハンドヘルド、膨張、誘導、電気外科、内視鏡)]、用途 (CVD、胸部、神経、耳鼻咽喉科、産婦人科、整形外科)、エンドユーザー – 2029年までの世界予測
Minimally Invasive Surgery Market by Product (Robotics, Imaging, Instrument (Handheld, inflation, Guiding, electrosurgery, endoscopy)), Application (CVD, thoracic, neuro, ENT, OB/GYN, orthopedic), Enduser – Global Forecast to 2029
| ページ数 | 348 |
| 図表数 | 377 |
| 価格 | |
| シングルユーザライセンス | USD 4,950 |
| マルチユーザライセンス（5名） | USD 6,650 |
| コーポレート（サイト）ライセンス | USD 8,150 |
| エンタープライズライセンス | USD 10,000 |
| 種別 | 英文調査報告書 |
Report Overview
The global minimally invasive surgery market is projected to reach USD 74.6 billion by 2029 from USD 34.0 billion in 2024, growing at a CAGR of 17.0% during the forecast period.
世界の低侵襲手術市場は、2024年の340億米ドルから2029年までに746億米ドルに達すると予測されており、予測期間中に17.0%のCAGRで成長します。
The projected surge in market growth for minimally invasive surgery is underpinned by a confluence of advantages. Minimally invasive surgery are driven by an aging population, rising adoption of MIS over open surgeries, and an increasing numbers of hospitals with the increase in the number of surgical procedures. Furthermore, the increasing incidences of chronic disorders with improved efficacy for early diagnosis through imaging and visualization systems and treatment amplifies the demand for advanced modalities, with minimally invasive surgery. These factors are poised to create the phase of robust expansion within the market, consequently shaping the minimally invasive surgerry adoption in the coming forecasting years.
“Cardio-thoracic surgery segment to register largest market share in 2023-2029.”
Based on the application, the minimally invasive surgery market is segmented into cardiothoracic, vascular urology, neurological surgeries, ENT & Respiratory surgery, Cosmetic surgery, Gastrointestinal & Abdominal surgery, Gynecological surgery, Orthopedic, Oncology, Dental and other surgery. The cardio-thoracic surgery segment registered the largest market share over the forecast period of 2023-2029. The growth of this segment is due to the continuous innovation in surgical techniques, instruments, and imaging technology enhances the feasibility and safety of minimally invasive approaches in cardio-thoracic surgery. As medical practitioners gain proficiency in MIS techniques, they demonstrate greater confidence in employing these methods for complex cardio-thoracic procedures. Moreover, evolving healthcare policies and reimbursement structures that promote cost-effective and efficient treatment pathways further incentivize the integration of MIS into cardio-thoracic surgery practices.
“Hospitals, Clinics & Ablation centers segment held the largest share of minimally invasive surgery market in 2023, by End-user.”
Based on the end-user, the minimally invasive surgery market is segmented into Hospitals, clinics & ablations centers, Ambulatory surgical centers and orthopedic, emergency and trauma centers. In 2023, the hospitals, clinics & ablation centers segment accounted for the largest share of the global minimally invasive surgery market. The growth of this segment is being propelled by factors including a significant portion of less invasive surgeries, ranging from routine procedures to complex interventions, adoption of advanced MIS technologies, and shaping trends with their clinical practices.
“Asia Pacific to register significant growth rate in the market during the forecast period.”
For the forecasting period 2024-2024, the APAC region is expected to register a significant growth rate during the forecast period. Asia Pacific comprises India, China, Japan, Australia, South Korea, and RoAPAC. The Asia-Pacific (APAC) region has witnessed a significant increase in the market growth rate for minimally invasive surgery. There are several drivers that contributed to this growth:
The Asia Pacific market is experiencing growth due to rising investments by government organisations in emerging countries aimed at enhancing healthcare infrastructure. Additionally, the market is benefiting from the rise in independent orthopedic, emergency and trauma centers, a substantial aging patient population, and strategic initiatives by industry players to expand their offerings of MIS products in the Asia Pacific region.
A breakdown of the primary participants referred to for this report is provided below:
• By Company Type: Tier 1–40%, Tier 2–30%, and Tier 3– 30%
• By Designation: C-level– 27%, Director-level–18%, and Others–55%
• By Region: North America–50%, Europe-20%, Asia Pacific–15%, Latin America–10%, and the Middle East & Africa–5%
Prominent players in this market are Medtronic (Ireland), Johnson & Johnson (US), Stryker Corporation (US), Boston Scientific Corporation (US), among others.
Research Coverage
• The report studies the minimally invasive surgery market based on products, application, end user, and region.
• The report analyzes factors (such as drivers, restraints, opportunities, and challenges) affecting the market growth.
• The report evaluates the opportunities and challenges in the market for stakeholders and provides details of the competitive landscape for market leaders.
• The report studies micro markets with respect to their growth trends, prospects, and contributions to the global minimally invasive surgery market
• The report forecasts the revenue of market segments with respect to five major regions.
Key Benefits of Buying the Report:
The report will help the new entrants/ market leaders/smaller firms in this market with investment evaluation viability within the minimally invasive surgery market through a thorough analysis of comprehensive data, thereby facilitating robust risk assessment and enabling well-informed investment determinations. Benefit from meticulous market segmentation encompassing application, end-user, and regional dimensions, affording tailored insights for precise segment targeting. The report also provides an all-encompassing evaluation of encapsulating pivotal trends, challenges, growth catalysts and prospects, thereby empowering strategic decision-making with astute discernment.
The report provides insights on the following pointers:
• Analysis of key drivers (increasing prevalence of chronic disorder diseases, Increasing number of hospitals coupled with increasing number of surgical procedures worldwide, adoption of MIS over open surgeries), restraints (changing regulatory landscape in medical device industry and high cost of robotic systems), opportunities (increasing adoption of advanced robotics in ASCs, Emerging markets offers high-growth opportunities), and challenges (High degree of market consolidation) influencing the growth of the minimally invasive surgery market
• Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and new product & service launches in the minimally invasive surgery market.
• Market Development: Comprehensive information about lucrative markets – the report analyses the minimally invasive surgery market across varied regions.
• Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the minimally invasive surgery market
• Competitive Assessment: In-depth assessment of market shares, growth strategies, and service offerings of leading players like Medtronic (Ireland), Johnson & Johnson (US), Stryker Corporation (US), Boston Scientific Corporation (US), among others.
Table of Contents
1 INTRODUCTION 41
1.1 STUDY OBJECTIVES 41
1.2 MARKET DEFINITION 41
1.2.1 INCLUSIONS AND EXCLUSIONS 42
1.3 MARKET SCOPE 43
1.3.1 MARKETS COVERED 43
1.3.2 REGIONS COVERED 43
1.3.3 YEARS CONSIDERED 44
1.3.4 CURRENCY CONSIDERED 44
1.4 MARKET STAKEHOLDERS 44
1.5 SUMMARY OF CHANGES 45
1.5.1 RECESSION IMPACT 45
2 RESEARCH METHODOLOGY 46
2.1 RESEARCH DATA 46
2.2 RESEARCH DESIGN 47
2.2.1 SECONDARY RESEARCH 47
2.2.1.1 Key data from secondary sources 49
2.2.2 PRIMARY RESEARCH 49
2.2.2.1 Primary sources 50
2.2.2.2 Key industry insights 51
2.2.2.3 Breakdown of primaries 51
FIGURE 1 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS 51
FIGURE 2 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION 52
2.3 MARKET SIZE ESTIMATION 52
FIGURE 3 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING 53
2.3.1 BOTTOM-UP APPROACH 53
2.3.1.1 Approach 1: Company revenue estimation approach 54
FIGURE 4 MINIMALLY INVASIVE SURGERY MARKET SIZE ESTIMATION: APPROACH 1 (COMPANY REVENUE ESTIMATION) 54
2.3.1.2 Approach 2: Customer-based market estimation 54
FIGURE 5 MINIMALLY INVASIVE SURGERY MARKET SIZE ESTIMATION: BOTTOM-UP APPROACH 55
2.3.1.3 Approach 3: Top-down approach 55
2.3.1.4 Approach 4: Primary interviews 55
FIGURE 6 TOP-DOWN APPROACH 56
2.4 DATA TRIANGULATION AND MARKET BREAKDOWN 58
FIGURE 7 DATA TRIANGULATION METHODOLOGY 58
2.5 RESEARCH LIMITATIONS 59
2.6 STUDY ASSUMPTIONS 59
2.7 RISK ASSESSMENT 60
TABLE 1 RISK ASSESSMENT ANALYSIS 60
2.8 GROWTH RATE ASSUMPTIONS 60
2.9 RECESSION IMPACT ANALYSIS 60
3 EXECUTIVE SUMMARY 62
FIGURE 8 MINIMALLY INVASIVE SURGERY MARKET, BY PRODUCT, 2024 VS. 2029 (USD MILLION) 62
FIGURE 9 MINIMALLY INVASIVE SURGERY MARKET, BY APPLICATION, 2024 VS. 2029 (USD MILLION) 63
FIGURE 10 MINIMALLY INVASIVE SURGERY MARKET, BY END USER, 2024 VS. 2029 (USD MILLION) 64
FIGURE 11 GEOGRAPHIC SNAPSHOT OF MINIMALLY INVASIVE SURGERY MARKET 65
4 PREMIUM INSIGHTS 66
4.1 MINIMALLY INVASIVE SURGERY MARKET OVERVIEW 66
FIGURE 12 INCREASING ADOPTION OF MIS OVER OPEN SURGERIES TO DRIVE MARKET DURING FORECAST PERIOD 66
4.2 MINIMALLY INVASIVE SURGERY MARKET, BY REGION, 2024 VS. 2029 (USD MILLION) 67
FIGURE 13 NORTH AMERICA TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD 67
4.3 MINIMALLY INVASIVE SURGERY MARKET, BY REGION AND END USER, 2023 (USD MILLION) 68
FIGURE 14 HOSPITALS, CLINICS, AND ABLATION CENTERS SEGMENT ACCOUNTED FOR LARGEST MARKET SHARE IN 2023 68
4.4 GEOGRAPHIC SNAPSHOT OF MINIMALLY INVASIVE SURGERY MARKET 69
FIGURE 15 FRANCE TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD 69
5 MARKET OVERVIEW 70
5.1 MARKET DYNAMICS 70
FIGURE 16 MINIMALLY INVASIVE SURGERY MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 70
5.1.1 DRIVERS 70
5.1.1.1 Increasing number of hospitals and surgeries 70
5.1.1.2 Increasing adoption of MIS over open surgeries 72
5.1.1.3 Advantages of robot-assisted surgery & training in rehabilitation therapy 73
5.1.1.4 Technological advancements 73
TABLE 2 TECHNOLOGICAL ADVANCEMENTS IN MEDICAL ROBOTS 73
5.1.2 RESTRAINTS 74
5.1.2.1 Changing regulatory landscape in medical devices 74
5.1.2.2 High cost of robotic systems 74
5.1.3 OPPORTUNITIES 75
5.1.3.1 Emerging markets 75
5.1.3.2 Increasing adoption of advanced robotics in ASCs 75
5.1.4 CHALLENGES 76
5.1.4.1 High degree of market consolidation 76
5.2 PORTER’S FIVE FORCES ANALYSIS 76
TABLE 3 MINIMALLY INVASIVE SURGERY MARKET: PORTER’S FIVE FORCES ANALYSIS 76
5.2.1 THREAT OF NEW ENTRANTS 77
5.2.2 THREAT OF SUBSTITUTES 77
5.2.3 BARGAINING POWER OF SUPPLIERS 77
5.2.4 BARGAINING POWER OF BUYERS 77
5.2.5 DEGREE OF COMPETITION 77
5.3 TARIFF AND REGULATORY LANDSCAPE 78
5.3.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 78
TABLE 4 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 78
TABLE 5 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 78
TABLE 6 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 79
TABLE 7 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 79
TABLE 8 MIDDLE EAST & AFRICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 80
5.4 KEY REGULATORY GUIDELINES 80
5.4.1 US 80
TABLE 9 US FDA: MEDICAL DEVICE REGULATORY APPROVAL PROCESS 81
5.4.2 EUROPE 82
5.4.3 JAPAN 83
5.5 ECOSYSTEM ANALYSIS 83
FIGURE 17 MINIMALLY INVASIVE SURGERY MARKET: ECOSYSTEM 83
FIGURE 18 MINIMALLY INVASIVE SURGERY MARKET: KEY PLAYERS 84
5.6 TECHNOLOGY ANALYSIS 84
5.6.1 KEY TECHNOLOGIES 84
5.6.1.1 Laparoscopy 84
5.6.1.2 Ablation 84
5.6.1.3 Electrosurgery 85
5.6.1.4 Powered surgical products 85
5.6.2 COMPLIMENTARY TECHNOLOGIES 85
5.6.2.1 Robotic surgery 85
5.6.2.2 Digital solutions (AI, IoT) 85
5.6.2.3 Medical/Surgical imaging 86
5.6.3 ADJACENT TECHNOLOGIES 86
5.6.3.1 Endoscopes 86
5.6.3.2 Surgical implants 86
5.7 VALUE CHAIN ANALYSIS 86
5.7.1 RESEARCH & DEVELOPMENT 87
5.7.2 PROCUREMENT & PRODUCT DEVELOPMENT 87
5.7.3 MARKETING, SALES AND DISTRIBUTION, AND POST-SALES SERVICES 87
FIGURE 19 MINIMALLY INVASIVE SURGERY MARKET: VALUE CHAIN ANALYSIS 87
5.8 SUPPLY CHAIN ANALYSIS 88
5.8.1 PROMINENT COMPANIES 88
5.8.2 SMALL & MEDIUM-SIZED COMPANIES 88
5.8.3 END USERS 88
FIGURE 20 MINIMALLY INVASIVE SURGERY MARKET: SUPPLY CHAIN ANALYSIS 88
5.9 KEY STAKEHOLDERS AND BUYING CRITERIA 89
5.9.1 KEY STAKEHOLDERS IN BUYING PROCESS 89
TABLE 10 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR KEY PRODUCT SEGMENTS (%) 89
5.9.2 KEY BUYING CRITERIA 89
5.10 REIMBURSEMENT SCENARIO 90
TABLE 11 REIMBURSEMENT CODES FOR VARIOUS PROCEDURES 90
5.11 PRICING ANALYSIS 90
FIGURE 21 AVERAGE SELLING PRICE OF MINIMALLY INVASIVE PRODUCTS, BY PRODUCT (FY 2021-2023) 90
FIGURE 22 AVERAGE SELLING PRICE TREND, BY REGION 91
5.12 PATENT ANALYSIS 92
FIGURE 23 PATENT DETAILS FOR MINIMALLY INVASIVE SURGERY DEVICES (JANUARY 2013–DECEMBER 2023) 92
5.13 TRADE ANALYSIS 93
TABLE 12 IMPORT DATA FOR MIS MARKET (HS CODE 9021), BY COUNTRY, 2018–2022 (USD THOUSAND) 93
TABLE 13 EXPORT DATA FOR MIS MARKET (HS CODE 3822), BY COUNTRY, 2018–2022 (USD THOUSAND) 94
5.14 CASE STUDIES 94
TABLE 14 CASE STUDY 1: ROLE OF MINIMALLY INVASIVE ROBOT-ASSISTED SURGERY IN UROLOGY 94
TABLE 15 CASE STUDY 2: PIONEERING ROBOT-ASSISTED LATERAL LUMBAR INTERBODY FUSION (LLIF) WITH EXCELSIUSGPS 95
5.15 KEY CONFERENCES AND EVENTS, 2023–2024 95
TABLE 16 MINIMALLY INVASIVE SURGERY MARKET: DETAILED LIST OF KEY CONFERENCES AND EVENTS IN 2023–2024 95
5.16 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 96
FIGURE 24 EMERGING TRENDS AND OPPORTUNITIES AFFECTING FUTURE REVENUE MIX 96
5.17 MINIMALLY INVASIVE SURGERY MARKET: RECESSION IMPACT 97
5.18 UNMET CUSTOMER NEEDS IN MINIMALLY INVASIVE SURGERY MARKET 97
5.19 INVESTMENT SCENARIO 98
FIGURE 25 NUMBER OF INVESTOR DEALS IN MINIMALLY INVASIVE SURGERY MARKET, BY KEY PLAYER, 2018–2022 98
FIGURE 26 VALUE OF INVESTOR DEALS IN MINIMALLY INVASIVE SURGERY MARKET, BY KEY PLAYER, 2018–2022 (USD MILLION) 98
6 MINIMALLY INVASIVE SURGERY MARKET, BY PRODUCT 99
6.1 INTRODUCTION 100
TABLE 17 MINIMALLY INVASIVE SURGERY MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 100
6.2 SURGICAL DEVICES 100
TABLE 18 SURGICAL DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 101
TABLE 19 SURGICAL DEVICES MARKET, BY REGION, 2022–2029 (USD MILLION) 101
6.2.1 HANDHELD INSTRUMENTS 101
TABLE 20 HANDHELD INSTRUMENTS MARKET, BY REGION, 2022–2029 (USD MILLION) 102
6.2.1.1 Tubular retractors 102
6.2.1.1.1 Minimized tissue trauma and better outcomes to support adoption 102
6.2.1.2 Dilators 102
6.2.1.2.1 Safety and efficient surgical site access to support adoption 102
6.2.1.3 Suturing instruments 103
6.2.1.3.1 Rising procedural volume and growing demand for MIS to drive market 103
6.2.1.4 Probes 103
6.2.1.4.1 Advancements in instrumentation and product launches to drive market 103
6.2.1.5 Laser fiber devices 103
6.2.1.5.1 Growing demand in urology, gastroenterology, and other specialties to support market growth 103
6.2.2 GUIDING DEVICES 104
TABLE 21 GUIDING DEVICES MARKET, BY REGION, 2022–2029 (USD MILLION) 104
6.2.2.1 Guiding catheters 104
6.2.2.1.1 Focus on functional and design improvements to drive demand 104
6.2.2.2 Guidewires 104
6.2.2.2.1 Rising PCTA and PTA procedural volumes to ensure demand growth 104
6.2.3 INFLATION SYSTEMS 105
TABLE 22 INFLATION SYSTEMS MARKET, BY REGION, 2022–2029 (USD MILLION) 105
6.2.3.1 Balloon catheters 106
6.2.3.1.1 Technological advancements in balloon systems to support growth 106
6.2.3.2 Balloon inflation systems 106
6.2.3.2.1 Growing adoption of MIS in coronary and peripheral disease treatment to drive market 106
6.2.4 LAPAROSCOPY DEVICES 107
TABLE 23 LAPAROSCOPY DEVICES MARKET, BY REGION, 2022–2029 (USD MILLION) 107
6.2.4.1 Laparoscopes 107
6.2.4.1.1 Lower risk of laparoscopic procedures to drive demand 107
6.2.4.2 Trocars & cannulas 108
6.2.4.2.1 Need to ensure accurate placement to support growth 108
6.2.4.3 Graspers & dissectors 108
6.2.4.3.1 Benefits such as increased safety and better reach to drive adoption 108
6.3 IMAGING & VISUALIZATION SYSTEMS 108
TABLE 24 IMAGING & VISUALIZATION SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION) 109
TABLE 25 IMAGING & VISUALIZATION SYSTEMS MARKET, BY REGION, 2022–2029 (USD MILLION) 109
6.3.1 ULTRASOUND SYSTEMS 109
6.3.1.1 Ultrasound to hold largest share of imaging & visualization systems market 109
TABLE 26 ULTRASOUND SYSTEMS MARKET, BY REGION, 2022–2029 (USD MILLION) 110
6.3.2 CT SCANNERS 110
6.3.2.1 Shift toward image-guided interventions and rising disease prevalence to drive market 110
TABLE 27 CT SCANNERS MARKET, BY REGION, 2022–2029 (USD MILLION) 111
6.3.3 MRI SYSTEMS 111
6.3.3.1 Wide usage and technological advancements to support growth 111
TABLE 28 MRI SYSTEMS MARKET, BY REGION, 2022–2029 (USD MILLION) 111
6.3.4 X-RAY SYSTEMS 112
6.3.4.1 Rising emphasis on digital X-ray systems to drive market 112
TABLE 29 X-RAY SYSTEMS MARKET, BY REGION, 2022–2029 (USD MILLION) 112
6.3.5 VISUALIZATION SYSTEMS 112
6.3.5.1 High levels of detail and better outcomes to drive demand 112
TABLE 30 VISUALIZATION SYSTEMS MARKET, BY REGION, 2022–2029 (USD MILLION) 113
6.4 ELECTROSURGICAL DEVICES 113
TABLE 31 ELECTROSURGICAL DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 114
TABLE 32 ELECTROSURGICAL DEVICES MARKET, BY REGION, 2022–2029 (USD MILLION) 114
6.4.1 ELECTROCAUTERY DEVICES 114
6.4.1.1 Increasing plastic surgeries to drive market 114
TABLE 33 ELECTROCAUTERY DEVICES MARKET, BY REGION, 2022–2029 (USD MILLION) 115
6.4.2 ELECTROSURGICAL GENERATORS & ACCESSORIES 115
6.4.2.1 Growing use of disposables and reusable instruments to drive market 115
TABLE 34 ELECTROSURGICAL GENERATORS & ACCESSORIES MARKET, BY REGION, 2022–2029 (USD MILLION) 115
6.5 ENDOSCOPY DEVICES 116
TABLE 35 ENDOSCOPY DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 116
TABLE 36 ENDOSCOPY DEVICES MARKET, BY REGION, 2022–2029 (USD MILLION) 116
6.5.1 RIGID ENDOSCOPES 117
6.5.1.1 Rigid endoscopes to hold largest market share 117
TABLE 37 RIGID ENDOSCOPES MARKET, BY REGION, 2022–2029 (USD MILLION) 117
6.5.2 FLEXIBLE ENDOSCOPES 117
6.5.2.1 Rising incidence of cancer to drive demand 117
TABLE 38 FLEXIBLE ENDOSCOPES MARKET, BY REGION, 2022–2029 (USD MILLION) 118
6.5.3 DIAGNOSTIC ENDOSCOPES 118
6.5.3.1 Role of diagnostic endoscopes to expand due to versatility and sophistication 118
TABLE 39 DIAGNOSTIC ENDOSCOPES MARKET, BY REGION, 2022–2029 (USD MILLION) 119
6.6 MEDICAL ROBOTICS 119
TABLE 40 MEDICAL ROBOTICS MARKET, BY TYPE, 2022–2029 (USD MILLION) 119
TABLE 41 MEDICAL ROBOTICS MARKET, BY REGION, 2022–2029 (USD MILLION) 120
6.6.1 ROBOTIC SYSTEMS 120
6.6.1.1 Accuracy, efficiency, and ability to conduct highly complex procedures to support market growth 120
TABLE 42 ROB0TIC SYSTEMS MARKET, BY REGION, 2022–2029 (USD MILLION) 120
6.6.2 ROBOTIC INSTRUMENTS 121
6.6.2.1 Rising demand for robotic surgical procedures to drive market 121
TABLE 43 ROB0TIC INSTRUMENTS MARKET, BY REGION, 2022–2029 (USD MILLION) 121
6.6.3 ROBOTIC SOFTWARE & SERVICES 121
6.6.3.1 Need for basic training and expertise in robotic systems to drive market 121
TABLE 44 ROBOTIC SOFTWARE & SERVICES MARKET, BY REGION, 2022–2029 (USD MILLION) 121
7 MINIMALLY INVASIVE SURGERY MARKET, BY APPLICATION 122
7.1 INTRODUCTION 123
TABLE 45 MINIMALLY INVASIVE SURGERY MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 123
7.2 CARDIOTHORACIC SURGERY 124
7.2.1 GROWING BURDEN OF CARDIOVASCULAR DISEASES TO DRIVE MARKET 124
TABLE 46 MINIMALLY INVASIVE SURGERY MARKET FOR CARDIOTHORACIC SURGERY, BY REGION, 2022–2029 (USD MILLION) 125
7.3 VASCULAR SURGERY 125
7.3.1 BENEFITS SUCH AS PRECISE CUTS WITH LIMITED BLOOD LOSS IN VASCULAR SURGERY TO SUPPORT GROWTH 125
TABLE 47 MINIMALLY INVASIVE SURGERY MARKET FOR VASCULAR SURGERY, BY REGION, 2022–2029 (USD MILLION) 126
7.4 NEUROLOGICAL SURGERY 126
7.4.1 INCREASING NUMBER OF PATIENTS SUFFERING FROM NEUROLOGICAL DISORDERS TO DRIVE SEGMENT GROWTH 126
TABLE 48 MINIMALLY INVASIVE SURGERY MARKET FOR NEUROLOGICAL SURGERY, BY REGION, 2022–2029 (USD MILLION) 127
7.5 ENT & RESPIRATORY SURGERY 127
7.5.1 BENEFITS OF MIS IN HEAD AND NECK DISORDER TREATMENT TO DRIVE MARKET 127
TABLE 49 MINIMALLY INVASIVE SURGERY MARKET FOR ENT & RESPIRATORY SURGERY, BY REGION, 2022–2029 (USD MILLION) 128
7.6 COSMETIC SURGERY 128
7.6.1 GROWING PREFERENCE FOR COSMETIC PROCEDURES TO DRIVE MARKET 128
TABLE 50 MINIMALLY INVASIVE SURGERY MARKET FOR COSMETIC SURGERY, BY REGION, 2022–2029 (USD MILLION) 129
7.7 GASTROINTESTINAL & ABDOMINAL SURGERY 129
7.7.1 RISING COLORECTAL CANCER PREVALENCE TO SUPPORT DEMAND 129
TABLE 51 MINIMALLY INVASIVE SURGERY MARKET FOR GASTROINTESTINAL & ABDOMINAL SURGERY, BY REGION, 2022–2029 (USD MILLION) 130
7.8 GYNECOLOGICAL SURGERY 130
7.8.1 GROWING NUMBER OF LAPAROSCOPIC HYSTERECTOMIES PERFORMED TO SUPPORT MARKET GROWTH 130
TABLE 52 MINIMALLY INVASIVE SURGERY MARKET FOR GYNECOLOGICAL SURGERY, BY REGION, 2022–2029 (USD MILLION) 131
7.9 UROLOGICAL SURGERY 131
7.9.1 INCREASING PREVALENCE OF UROLOGIC CANCERS TO DRIVE ADOPTION OF MIS 131
TABLE 53 MINIMALLY INVASIVE SURGERY MARKET FOR UROLOGICAL SURGERY, BY REGION, 2022–2029 (USD MILLION) 132
7.10 ORTHOPEDIC SURGERY 132
7.10.1 RISING GERIATRIC POPULATION AND INCREASE IN ORTHOPEDIC DISORDERS TO DRIVE MARKET 132
TABLE 54 MINIMALLY INVASIVE SURGERY MARKET FOR ORTHOPEDIC SURGERY, BY REGION, 2022–2029 (USD MILLION) 133
7.11 ONCOLOGICAL SURGERY 133
7.11.1 GROWING DEMAND FOR RADIOTHERAPY AND CHEMOTHERAPY TO AFFECT SEGMENT GROWTH 133
TABLE 55 MINIMALLY INVASIVE SURGERY MARKET FOR ONCOLOGICAL SURGERY, BY REGION, 2022–2029 (USD MILLION) 134
7.12 DENTAL SURGERY 134
7.12.1 EMPHASIS ON PREVENTIVE DENTAL CARE TO SUPPORT MARKET GROWTH 134
TABLE 56 MINIMALLY INVASIVE SURGERY MARKET FOR DENTAL SURGERY, BY REGION, 2022–2029 (USD MILLION) 135
7.13 OTHER SURGERIES 135
TABLE 57 MINIMALLY INVASIVE SURGERY MARKET FOR OTHER SURGERIES, BY REGION, 2022–2029 (USD MILLION) 136
8 MINIMALLY INVASIVE SURGERY MARKET, BY END USER 137
8.1 INTRODUCTION 138
TABLE 58 MINIMALLY INVASIVE SURGERY MARKET, BY END USER, 2022–2029 (USD MILLION) 138
8.2 HOSPITALS, CLINICS, AND ABLATION CENTERS 138
8.2.1 RISING NUMBER OF HOSPITALS AND GOVERNMENT INVESTMENTS TO DRIVE MARKET 138
TABLE 59 MINIMALLY INVASIVE SURGERY MARKET FOR HOSPITALS, CLINICS AND ABLATION CENTERS, BY REGION, 2022–2029 (USD MILLION) 139
8.3 AMBULATORY SURGERY CENTERS 140
8.3.1 LOWER COSTS AND SHORTER PATIENT STAYS TO PROPEL GROWTH 140
TABLE 60 MINIMALLY INVASIVE SURGERY MARKET FOR AMBULATORY SURGERY CENTERS, BY REGION, 2022–2029 (USD MILLION) 141
8.4 ORTHOPEDIC, EMERGENCY, AND TRAUMA CENTERS 141
8.4.1 RISING USE OF ROBOTIC-ASSISTED SURGICAL SYSTEMS IN ORTHOPEDICS, EMERGENCY, AND TRAUMA CARE TO SUPPORT GROWTH 141
TABLE 61 MINIMALLY INVASIVE SURGERY MARKET FOR ORTHOPEDIC, EMERGENCY, AND TRAUMA CENTERS, BY REGION, 2022–2029 (USD MILLION) 142
8.5 OTHER END USERS 142
TABLE 62 MINIMALLY INVASIVE SURGERY MARKET FOR OTHER END USERS, BY REGION, 2022–2029 (USD MILLION) 143
9 MINIMALLY INVASIVE SURGERY MARKET, BY REGION 144
9.1 INTRODUCTION 145
TABLE 63 MINIMALLY INVASIVE SURGERY MARKET, BY REGION, 2022–2029 (USD MILLION) 145
9.2 NORTH AMERICA 145
9.2.1 NORTH AMERICA: RECESSION IMPACT 146
FIGURE 27 NORTH AMERICA: MINIMALLY INVASIVE SURGERY MARKET SNAPSHOT 146
TABLE 64 NORTH AMERICA: MINIMALLY INVASIVE SURGERY MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 147
TABLE 65 NORTH AMERICA: MINIMALLY INVASIVE SURGERY MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 147
TABLE 66 NORTH AMERICA: SURGICAL DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 148
TABLE 67 NORTH AMERICA: IMAGING & VISUALIZATION SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION) 148
TABLE 68 NORTH AMERICA: ELECTROSURGICAL DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 149
TABLE 69 NORTH AMERICA: ENDOSCOPY DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 149
TABLE 70 NORTH AMERICA: MEDICAL ROBOTICS MARKET, BY TYPE, 2022–2029 (USD MILLION) 149
TABLE 71 NORTH AMERICA: MINIMALLY INVASIVE SURGERY MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 150
TABLE 72 NORTH AMERICA: MINIMALLY INVASIVE SURGERY MARKET, BY END USER, 2022–2029 (USD MILLION) 150
9.2.2 US 151
9.2.2.1 US to dominate North American market 151
TABLE 73 US: MINIMALLY INVASIVE SURGERY MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 152
TABLE 74 US: SURGICAL DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 152
TABLE 75 US: IMAGING & VISUALIZATION SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION) 153
TABLE 76 US: ELECTROSURGICAL DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 153
TABLE 77 US: ENDOSCOPY DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 154
TABLE 78 US: MEDICAL ROBOTICS MARKET, BY TYPE, 2022–2029 (USD MILLION) 154
9.2.3 CANADA 154
9.2.3.1 Rising cancer and IBD incidence to drive market 154
TABLE 79 CANADA: MINIMALLY INVASIVE SURGERY MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 155
TABLE 80 CANADA: SURGICAL DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 156
TABLE 81 CANADA: IMAGING & VISUALIZATION SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION) 156
TABLE 82 CANADA: ELECTROSURGICAL DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 157
TABLE 83 CANADA: ENDOSCOPY DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 157
TABLE 84 CANADA: MEDICAL ROBOTICS MARKET, BY TYPE, 2022–2029 (USD MILLION) 157
9.3 EUROPE 158
9.3.1 EUROPE: RECESSION IMPACT 158
TABLE 85 EUROPE: MINIMALLY INVASIVE SURGERY MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 159
TABLE 86 EUROPE: MINIMALLY INVASIVE SURGERY MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 159
TABLE 87 EUROPE: SURGICAL DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 160
TABLE 88 EUROPE: IMAGING & VISUALIZATION SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION) 160
TABLE 89 EUROPE: ELECTROSURGICAL DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 161
TABLE 90 EUROPE: ENDOSCOPY DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 161
TABLE 91 EUROPE: MEDICAL ROBOTICS MARKET, BY TYPE, 2022–2029 (USD MILLION) 161
TABLE 92 EUROPE: MINIMALLY INVASIVE SURGERY MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 162
TABLE 93 EUROPE: MINIMALLY INVASIVE SURGERY MARKET, BY END USER, 2022–2029 (USD MILLION) 162
9.3.2 GERMANY 163
9.3.2.1 Well-established healthcare system in Germany to boost usage of instruments 163
TABLE 94 GERMANY: MINIMALLY INVASIVE SURGERY MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 163
TABLE 95 GERMANY: SURGICAL DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 164
TABLE 96 GERMANY: IMAGING & VISUALIZATION SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION) 164
TABLE 97 GERMANY: ELECTROSURGICAL DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 165
TABLE 98 GERMANY: ENDOSCOPY DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 165
TABLE 99 GERMANY: MEDICAL ROBOTICS MARKET, BY TYPE, 2022–2029 (USD MILLION) 165
9.3.3 FRANCE 166
9.3.3.1 Rising number of hip & knee surgeries to drive market 166
TABLE 100 FRANCE: MINIMALLY INVASIVE SURGERY MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 166
TABLE 101 FRANCE: SURGICAL DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 167
TABLE 102 FRANCE: IMAGING & VISUALIZATION SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION) 167
TABLE 103 FRANCE: ELECTROSURGICAL DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 168
TABLE 104 FRANCE: ENDOSCOPY DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 168
TABLE 105 FRANCE: MEDICAL ROBOTICS MARKET, BY TYPE, 2022–2029 (USD MILLION) 168
9.3.4 UK 169
9.3.4.1 High incidence of cancer in the UK to boost adoption of MIS instruments 169
TABLE 106 UK: MINIMALLY INVASIVE SURGERY MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 169
TABLE 107 UK: SURGICAL DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 170
TABLE 108 UK: IMAGING & VISUALIZATION SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION) 170
TABLE 109 UK: ELECTROSURGICAL DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 171
TABLE 110 UK: ENDOSCOPY DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 171
TABLE 111 UK: MEDICAL ROBOTICS MARKET, BY TYPE, 2022–2029 (USD MILLION) 171
9.3.5 ITALY 172
9.3.5.1 Demand for MIS to positively affect market growth 172
TABLE 112 ITALY: MINIMALLY INVASIVE SURGERY MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 172
TABLE 113 ITALY: SURGICAL DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 173
TABLE 114 ITALY: IMAGING & VISUALIZATION SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION) 173
TABLE 115 ITALY: ELECTROSURGICAL DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 174
TABLE 116 ITALY: ENDOSCOPY DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 174
TABLE 117 ITALY: MEDICAL ROBOTICS MARKET, BY TYPE, 2022–2029 (USD MILLION) 174
9.3.6 SPAIN 175
9.3.6.1 Increasing incidence of CVD to boost adoption of MIS and drive market growth 175
TABLE 118 SPAIN: MINIMALLY INVASIVE SURGERY MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 175
TABLE 119 SPAIN: SURGICAL DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 175
TABLE 120 SPAIN: IMAGING & VISUALIZATION SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION) 176
TABLE 121 SPAIN: ELECTROSURGICAL DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 176
TABLE 122 SPAIN: ENDOSCOPY DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 177
TABLE 123 SPAIN: MEDICAL ROBOTICS MARKET, BY TYPE, 2022–2029 (USD MILLION) 177
9.3.7 REST OF EUROPE 177
TABLE 124 REST OF EUROPE: MINIMALLY INVASIVE SURGERY MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 178
TABLE 125 REST OF EUROPE: SURGICAL DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 178
TABLE 126 REST OF EUROPE: IMAGING & VISUALIZATION SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION) 179
TABLE 127 REST OF EUROPE: ELECTROSURGICAL DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 179
TABLE 128 REST OF EUROPE: ENDOSCOPY DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 180
TABLE 129 REST OF EUROPE: MEDICAL ROBOTICS MARKET, BY TYPE, 2022–2029 (USD MILLION) 180
9.4 ASIA PACIFIC 181
9.4.1 ASIA PACIFIC: RECESSION IMPACT 181
FIGURE 28 ASIA PACIFIC: MINIMALLY INVASIVE SURGERY MARKET SNAPSHOT 182
TABLE 130 ASIA PACIFIC: MINIMALLY INVASIVE SURGERY MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 183
TABLE 131 ASIA PACIFIC: MINIMALLY INVASIVE SURGERY MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 183
TABLE 132 ASIA PACIFIC: SURGICAL DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 184
TABLE 133 ASIA PACIFIC: IMAGING & VISUALIZATION SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION) 184
TABLE 134 ASIA PACIFIC: ELECTROSURGICAL DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 185
TABLE 135 ASIA PACIFIC: ENDOSCOPY DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 185
TABLE 136 ASIA PACIFIC: MEDICAL ROBOTICS MARKET, BY TYPE, 2022–2029 (USD MILLION) 185
TABLE 137 ASIA PACIFIC: MINIMALLY INVASIVE SURGERY MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 186
TABLE 138 ASIA PACIFIC: MINIMALLY INVASIVE SURGERY MARKET, BY END USER, 2022–2029 (USD MILLION) 186
9.4.2 JAPAN 187
9.4.2.1 Rising geriatric population in Japan to increase prevalence of chronic conditions and support market growth 187
TABLE 139 JAPAN: MINIMALLY INVASIVE SURGERY MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 187
TABLE 140 JAPAN: SURGICAL DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 188
TABLE 141 JAPAN: IMAGING & VISUALIZATION SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION) 188
TABLE 142 JAPAN: ELECTROSURGICAL DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 189
TABLE 143 JAPAN: ENDOSCOPY DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 189
TABLE 144 JAPAN: MEDICAL ROBOTICS MARKET, BY TYPE, 2022–2029 (USD MILLION) 189
9.4.3 CHINA 190
9.4.3.1 Rising disease prevalence and infrastructural improvements to support market growth 190
TABLE 145 CHINA: MINIMALLY INVASIVE SURGERY MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 190
TABLE 146 CHINA: SURGICAL DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 191
TABLE 147 CHINA: IMAGING & VISUALIZATION SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION) 191
TABLE 148 CHINA: ELECTROSURGICAL DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 192
TABLE 149 CHINA: ENDOSCOPY DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 192
TABLE 150 CHINA: MEDICAL ROBOTICS MARKET, BY TYPE, 2022–2029 (USD MILLION) 192
9.4.4 INDIA 193
9.4.4.1 Healthcare infrastructure improvements and increasing geriatric population to drive market 193
TABLE 151 INDIA: MINIMALLY INVASIVE SURGERY MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 193
TABLE 152 INDIA: SURGICAL DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 194
TABLE 153 INDIA: IMAGING & VISUALIZATION SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION) 194
TABLE 154 INDIA: ELECTROSURGICAL DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 195
TABLE 155 INDIA: ENDOSCOPY DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 195
TABLE 156 INDIA: MEDICAL ROBOTICS MARKET, BY TYPE, 2022–2029 (USD MILLION) 195
9.4.5 AUSTRALIA 196
9.4.5.1 Uneven distribution of specialists to hinder market growth 196
TABLE 157 AUSTRALIA: MINIMALLY INVASIVE SURGERY MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 196
TABLE 158 AUSTRALIA: SURGICAL DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 196
TABLE 159 AUSTRALIA: IMAGING & VISUALIZATION SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION) 197
TABLE 160 AUSTRALIA: ELECTROSURGICAL DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 197
TABLE 161 AUSTRALIA: ENDOSCOPY DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 198
TABLE 162 AUSTRALIA: MEDICAL ROBOTICS MARKET, BY TYPE, 2022–2029 (USD MILLION) 198
9.4.6 SOUTH KOREA 198
9.4.6.1 Growing medical tourism to favor demand for MIS 198
TABLE 163 SOUTH KOREA: MINIMALLY INVASIVE SURGERY MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 199
TABLE 164 SOUTH KOREA: SURGICAL DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 199
TABLE 165 SOUTH KOREA: IMAGING & VISUALIZATION SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION) 200
TABLE 166 SOUTH KOREA: ELECTROSURGICAL DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 200
TABLE 167 SOUTH KOREA: ENDOSCOPY DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 201
TABLE 168 SOUTH KOREA: MEDICAL ROBOTICS MARKET, BY TYPE, 2022–2029 (USD MILLION) 201
9.4.7 REST OF ASIA PACIFIC 201
TABLE 169 REST OF ASIA PACIFIC: MINIMALLY INVASIVE SURGERY MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 202
TABLE 170 REST OF ASIA PACIFIC: SURGICAL DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 203
TABLE 171 REST OF ASIA PACIFIC: IMAGING & VISUALIZATION SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION) 203
TABLE 172 REST OF ASIA PACIFIC: ELECTROSURGICAL DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 204
TABLE 173 REST OF ASIA PACIFIC: ENDOSCOPY DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 204
TABLE 174 REST OF ASIA PACIFIC: MEDICAL ROBOTICS MARKET, BY TYPE, 2022–2029 (USD MILLION) 204
9.5 LATIN AMERICA 205
9.5.1 LATIN AMERICA: RECESSION IMPACT 205
TABLE 175 LATIN AMERICA: MINIMALLY INVASIVE SURGERY MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 206
TABLE 176 LATIN AMERICA: MINIMALLY INVASIVE SURGERY MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 206
TABLE 177 LATIN AMERICA: SURGICAL DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 207
TABLE 178 LATIN AMERICA: IMAGING & VISUALIZATION SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION) 207
TABLE 179 LATIN AMERICA: ELECTROSURGICAL DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 208
TABLE 180 LATIN AMERICA: ENDOSCOPY DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 208
TABLE 181 LATIN AMERICA: MEDICAL ROBOTICS MARKET, BY TYPE, 2022–2029 (USD MILLION) 208
TABLE 182 LATIN AMERICA: MINIMALLY INVASIVE SURGERY MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 209
TABLE 183 LATIN AMERICA: MINIMALLY INVASIVE SURGERY MARKET, BY END USER, 2022–2029 (USD MILLION) 209
9.5.2 BRAZIL 210
9.5.2.1 Favorable healthcare policies by government and private organizations to propel market growth 210
TABLE 184 BRAZIL: MINIMALLY INVASIVE SURGERY MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 210
TABLE 185 BRAZIL: SURGICAL DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 211
TABLE 186 BRAZIL: IMAGING & VISUALIZATION SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION) 211
TABLE 187 BRAZIL: ELECTROSURGICAL DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 212
TABLE 188 BRAZIL: ENDOSCOPY DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 212
TABLE 189 BRAZIL: MEDICAL ROBOTICS MARKET, BY TYPE, 2022–2029 (USD MILLION) 212
9.5.3 MEXICO 213
9.5.3.1 Rising adoption of robotics in cosmetic surgeries to drive market 213
TABLE 190 MEXICO: MINIMALLY INVASIVE SURGERY MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 213
TABLE 191 MEXICO: SURGICAL DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 214
TABLE 192 MEXICO: IMAGING & VISUALIZATION SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION) 214
TABLE 193 MEXICO: ELECTROSURGICAL DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 215
TABLE 194 MEXICO: ENDOSCOPY DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 215
TABLE 195 MEXICO: MEDICAL ROBOTICS MARKET, BY TYPE, 2022–2029 (USD MILLION) 215
9.5.4 REST OF LATIN AMERICA 216
TABLE 196 REST OF LATIN AMERICA: MINIMALLY INVASIVE SURGERY MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 216
TABLE 197 REST OF LATIN AMERICA: SURGICAL DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 217
TABLE 198 REST OF LATIN AMERICA: IMAGING & VISUALIZATION SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION) 217
TABLE 199 REST OF LATIN AMERICA: ELECTROSURGICAL DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 218
TABLE 200 REST OF LATIN AMERICA: ENDOSCOPY DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 218
TABLE 201 REST OF LATIN AMERICA: MEDICAL ROBOTICS MARKET, BY TYPE, 2022–2029 (USD MILLION) 218
9.6 MIDDLE EAST & AFRICA 219
9.6.1 MIDDLE EAST & AFRICA: RECESSION IMPACT 219
TABLE 202 MIDDLE EAST & AFRICA: MINIMALLY INVASIVE SURGERY MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 220
TABLE 203 MIDDLE EAST & AFRICA: SURGICAL DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 220
TABLE 204 MIDDLE EAST & AFRICA: IMAGING & VISUALIZATION SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION) 221
TABLE 205 MIDDLE EAST & AFRICA: ELECTROSURGICAL DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 221
TABLE 206 MIDDLE EAST & AFRICA: ENDOSCOPY DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 222
TABLE 207 MIDDLE EAST & AFRICA: MEDICAL ROBOTICS MARKET, BY TYPE, 2022–2029 (USD MILLION) 222
TABLE 208 MIDDLE EAST & AFRICA: MINIMALLY INVASIVE SURGERY MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 223
TABLE 209 MIDDLE EAST & AFRICA: MINIMALLY INVASIVE SURGERY MARKET, BY END USER, 2022–2029 (USD MILLION) 223
9.6.2 GCC COUNTRIES 224
9.6.2.1 Growing demand for minimally invasive procedures 224
10 COMPETITIVE LANDSCAPE 225
10.1 OVERVIEW 225
10.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 225
FIGURE 29 OVERVIEW OF STRATEGIES ADOPTED BY MINIMALLY INVASIVE SURGERY PLAYERS 226
10.3 REVENUE SHARE ANALYSIS 227
FIGURE 30 REVENUE SHARE ANALYSIS FOR KEY PLAYERS, 2018–2022 (USD MILLION) 227
10.4 MARKET SHARE ANALYSIS 228
10.4.1 GLOBAL SURGICAL DEVICES MARKET SHARE, BY KEY PLAYER, 2022 228
FIGURE 31 SURGICAL DEVICES MARKET SHARE ANALYSIS, 2022 228
10.4.2 GLOBAL IMAGING & VISUALIZATION SYSTEMS MARKET SHARE, BY KEY PLAYER, 2022 228
FIGURE 32 IMAGING & VISUALIZATION SYSTEMS MARKET SHARE ANALYSIS, 2022 228
10.4.3 GLOBAL ENDOSCOPY DEVICES MARKET SHARE, BY KEY PLAYER, 2022 229
FIGURE 33 ENDOSCOPY DEVICES MARKET SHARE ANALYSIS, 2022 229
10.4.4 GLOBAL ELECTROSURGICAL DEVICES MARKET SHARE, BY KEY PLAYER, 2022 229
FIGURE 34 ELECTROSURGICAL DEVICES MARKET SHARE ANALYSIS, 2022 229
10.4.5 GLOBAL MEDICAL ROBOTICS MARKET SHARE, BY KEY PLAYER, 2022 230
FIGURE 35 MEDICAL ROBOTICS MARKET SHARE ANALYSIS, 2022 230
FIGURE 36 MINIMALLY INVASIVE SURGERY MARKET SHARE, BY PLAYER (2023) 231
TABLE 210 MINIMALLY INVASIVE SURGERY MARKET: DEGREE OF COMPETITION 231
10.5 COMPANY EVALUATION MATRIX (KEY PLAYERS) 232
10.5.1 STARS 232
10.5.2 EMERGING LEADERS 233
10.5.3 PERVASIVE PLAYERS 233
10.5.4 PARTICIPANTS 233
FIGURE 37 MINIMALLY INVASIVE SURGERY MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2022 233
10.5.5 COMPANY FOOTPRINT 234
FIGURE 38 COMPANY FOOTPRINT (15 COMPANIES) 234
TABLE 211 PRODUCT FOOTPRINT (15 COMPANIES) 234
TABLE 212 REGIONAL FOOTPRINT (15 COMPANIES) 235
TABLE 213 APPLICATION FOOTPRINT (15 COMPANIES) 236
10.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES 237
10.6.1 PROGRESSIVE COMPANIES 237
10.6.2 STARTING BLOCKS 237
10.6.3 RESPONSIVE COMPANIES 237
10.6.4 DYNAMIC COMPANIES 237
FIGURE 39 MINIMALLY INVASIVE SURGERY MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2022 238
10.6.5 COMPANY BENCHMARKING 239
TABLE 214 MINIMALLY INVASIVE SURGERY MARKET: DETAILED LIST OF KEY EMERGING PLAYERS/STARTUPS 239
TABLE 215 MINIMALLY INVASIVE SURGERY MARKET: COMPETITIVE BENCHMARKING OF KEY EMERGING PLAYERS/STARTUPS 240
10.7 COMPETITIVE SCENARIO 241
10.7.1 PRODUCT LAUNCHES & APPROVALS 241
TABLE 216 MINIMALLY INVASIVE SURGERY MARKET: PRODUCT LAUNCHES & APPROVALS (JANUARY 2021—OCTOBER 2023) 241
10.7.2 DEALS 242
TABLE 217 MINIMALLY INVASIVE SURGERY MARKET: DEALS (JANUARY 2021—OCTOBER 2023) 242
10.8 COMPANY VALUATION AND FINANCIAL METRICS 243
FIGURE 40 EV/EBITDA OF KEY VENDORS 243
FIGURE 41 5-YEAR STOCK BETA OF KEY VENDORS 243
10.9 PRODUCT/BRAND COMPARISON 244
FIGURE 42 BRAND/PRODUCT COMPARATIVE ANALYSIS, BY MODEL (2023) 244
11 COMPANY PROFILES 245
11.1 KEY PLAYERS 245
(Business Overview, Products/Services/Solutions Offered, MnM View, Key Strengths and Right to Win, Strategic Choices Made, Weaknesses and Competitive Threats, Recent Developments)*
11.1.1 MEDTRONIC PLC 245
TABLE 218 MEDTRONIC PLC: COMPANY OVERVIEW 245
FIGURE 43 MEDTRONIC PLC: COMPANY SNAPSHOT (2023) 246
TABLE 219 MEDTRONIC PLC: PRODUCTS OFFERED 247
TABLE 220 MEDTRONIC PLC: PRODUCT LAUNCHES & APPROVALS (JANUARY 2020–DECEMBER 2023) 251
TABLE 221 MEDTRONIC PLC: DEALS (JANUARY 2020–DECEMBER 2023) 251
11.1.2 JOHNSON & JOHNSON MEDTECH 253
TABLE 222 JOHNSON & JOHNSON MEDTECH: COMPANY OVERVIEW 253
FIGURE 44 JOHNSON & JOHNSON MEDTECH: COMPANY SNAPSHOT (2022) 254
TABLE 223 JOHNSON & JOHNSON MEDTECH: PRODUCTS OFFERED 254
TABLE 224 JOHNSON & JOHNSON: PRODUCT LAUNCHES & APPROVALS (JANUARY 2020–DECEMBER 2023) 257
TABLE 225 JOHNSON & JOHNSON: DEALS (JANUARY 2020–DECEMBER 2023) 258
11.1.3 STRYKER CORPORATION 259
TABLE 226 STRYKER CORPORATION: COMPANY OVERVIEW 259
FIGURE 45 STRYKER CORPORATION: COMPANY SNAPSHOT (2022) 260
TABLE 227 STRYKER CORPORATION: PRODUCTS OFFERED 260
TABLE 228 STRYKER CORPORATION: PRODUCT LAUNCHES & APPROVALS (JANUARY 2020–DECEMBER 2023) 261
TABLE 229 STRYKER CORPORATION: DEALS (JANUARY 2020–DECEMBER 2023) 262
11.1.4 BOSTON SCIENTIFIC CORPORATION 263
TABLE 230 BOSTON SCIENTIFIC CORPORATION: COMPANY OVERVIEW 263
FIGURE 46 BOSTON SCIENTIFIC CORPORATION: COMPANY SNAPSHOT (2022) 264
TABLE 231 BOSTON SCIENTIFIC CORPORATION: PRODUCTS OFFERED 264
TABLE 232 BOSTON SCIENTIFIC CORPORATION: PRODUCT LAUNCHES & APPROVALS (JANUARY 2020–DECEMBER 2023) 267
TABLE 233 BOSTON SCIENTIFIC CORPORATION: DEALS (JANUARY 2020–DECEMBER 2023) 267
11.1.5 ABBOTT LABORATORIES 269
TABLE 234 ABBOTT LABORATORIES: COMPANY OVERVIEW 269
FIGURE 47 ABBOTT LABORATORIES: COMPANY SNAPSHOT (2022) 270
TABLE 235 ABBOTT LABORATORIES: PRODUCTS OFFERED 270
TABLE 236 ABBOTT LABORATORIES: PRODUCT LAUNCHES & APPROVALS (JANUARY 2020–DECEMBER 2023) 271
11.1.6 ZIMMER BIOMET HOLDINGS, INC. 272
TABLE 237 ZIMMER BIOMET HOLDINGS, INC.: COMPANY OVERVIEW 272
FIGURE 48 ZIMMER BIOMET HOLDINGS: COMPANY SNAPSHOT (2022) 273
TABLE 238 ZIMMER BIOMET HOLDINGS: PRODUCTS OFFERED 273
TABLE 239 ZIMMER BIOMET HOLDINGS: PRODUCT APPROVALS (JANUARY 2020–DECEMBER 2023) 274
11.1.7 B. BRAUN MELSUNGEN AG 275
TABLE 240 B. BRAUN MELSUNGEN AG: COMPANY OVERVIEW 275
FIGURE 49 B. BRAUN MELSUNGEN AG: COMPANY SNAPSHOT (2022) 276
TABLE 241 B. BRAUN MELSUNGEN: PRODUCTS OFFERED 276
11.1.8 NUVASIVE, INC. 278
TABLE 242 NUVASIVE, INC: COMPANY OVERVIEW 278
FIGURE 50 NUVASIVE, INC: COMPANY SNAPSHOT (2022) 279
TABLE 243 NUVASIVE INC.: PRODUCTS OFFERED 279
TABLE 244 NUVASIVE, INC: PRODUCT LAUNCHES & APPROVALS (JANUARY 2020–DECEMBER 2023) 281
TABLE 245 NUVASIVE INC.: DEALS (JANUARY 2020–DECEMBER 2023) 281
11.1.9 INTEGRA LIFESCIENCES HOLDINGS CORPORATION 282
TABLE 246 INTEGRA LIFESCIENCES HOLDINGS CORPORATION: COMPANY OVERVIEW 282
FIGURE 51 INTEGRA LIFESCIENCES HOLDINGS CORPORATION: COMPANY SNAPSHOT (2023) 283
TABLE 247 INTEGRA LIFESCIENCES HOLDING CORPORATION: PRODUCTS OFFERED 283
11.1.10 ATEC SPINE 285
TABLE 248 ATEC SPINE: COMPANY OVERVIEW 285
FIGURE 52 ATEC SPINE: COMPANY SNAPSHOT (2022) 285
TABLE 249 ATEC SPINE: PRODUCTS OFFERED 286
11.1.11 SIEMENS HEALTHINEERS AG 287
TABLE 250 SIEMENS HEALTHINEERS AG: COMPANY OVERVIEW 287
FIGURE 53 SIEMENS HEALTHINEERS: COMPANY SNAPSHOT (2022) 288
TABLE 251 SIEMENS HEALTHINEERS AG: PRODUCTS OFFERED 288
TABLE 252 SIEMENS HEALTHINEERS AG: PRODUCT LAUNCHES, ENHANCEMENTS, AND APPROVALS (JANUARY 2020–DECEMBER 2023) 290
TABLE 253 SIEMENS HEALTHINEERS AG: DEALS (JANUARY 2020–DECEMBER 2023) 291
TABLE 254 SIEMENS HEALTHINEERS AG: EXPANSIONS (JANUARY 2020–DECEMBER 2023) 292
11.1.12 COOK MEDICAL 293
TABLE 255 COOK MEDICAL: COMPANY OVERVIEW 293
TABLE 256 COOK MEDICAL: PRODUCTS OFFERED 294
11.1.13 FUJIFILM CORPORATION 295
TABLE 257 FUJIFILM CORPORATION: COMPANY OVERVIEW 295
FIGURE 54 FUJIFILM CORPORATION: COMPANY SNAPSHOT (2022) 296
TABLE 258 FUJIFILM CORPORATION: PRODUCTS OFFERED 296
TABLE 259 FUJIFILM CORPORATION: PRODUCT LAUNCHES & APPROVALS (JANUARY 2020–DECEMBER 2023) 298
TABLE 260 FUJIFILM CORPORATION: DEALS (JANUARY 2020–DECEMBER 2023) 300
TABLE 261 FUJIFILM CORPORATION: EXPANSION (JANUARY 2020–DECEMBER 2023) 300
TABLE 262 FUJIFILM CORPORATION: OTHER DEVELOPMENTS (JANUARY 2020–DECEMBER 2023) 301
11.1.14 BECTON, DICKINSON AND COMPANY 302
TABLE 263 BECTON, DICKINSON AND COMPANY: COMPANY OVERVIEW 302
FIGURE 55 BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT (2022) 303
TABLE 264 BECTON, DICKINSON AND COMPANY: PRODUCTS OFFERED 303
TABLE 265 BECTON, DICKINSON AND COMPANY: DEALS (JANUARY 2020–DECEMBER 2023) 304
TABLE 266 BECTON, DICKINSON AND COMPANY: OTHER DEVELOPMENTS (JANUARY 2020–DECEMBER 2023) 304
11.1.15 PHILIPS HEALTHCARE 305
TABLE 267 PHILIPS HEALTHCARE: COMPANY OVERVIEW 305
FIGURE 56 PHILIPS HEALTHCARE: COMPANY SNAPSHOT (2022) 306
TABLE 268 PHILIPS HEALTHCARE: PRODUCTS OFFERED 306
TABLE 269 PHILIPS HEALTHCARE: PRODUCT LAUNCHES & APPROVALS (JANUARY 2020–DECEMBER 2023) 308
TABLE 270 PHILIPS HEALTHCARE: DEALS (JANUARY 2020–DECEMBER 2023) 309
11.1.16 GLOBUS MEDICAL, INC. 310
TABLE 271 GLOBUS MEDICAL, INC.: COMPANY OVERVIEW 310
FIGURE 57 GLOBUS MEDICAL, INC.: COMPANY SNAPSHOT (2022) 311
TABLE 272 GLOBUS MEDICAL: PRODUCTS OFFERED 311
TABLE 273 GLOBUS MEDICAL: PRODUCT LAUNCHES & APPROVALS (JANUARY 2020–DECEMBER 2023) 312
11.2 OTHER PLAYERS 313
11.2.1 INTUITIVE SURGICAL INC. 313
TABLE 274 INTUITIVE SURGICAL INC.: COMPANY OVERVIEW 313
FIGURE 58 INTUITIVE SURGICAL INC.: COMPANY SNAPSHOT (2022) 314
TABLE 275 INTUITIVE SURGICAL INC.: PRODUCTS OFFERED 314
TABLE 276 INTUITIVE SURGICAL, INC.: PRODUCT LAUNCHES & APPROVALS (JANUARY 2020–DECEMBER 2023) 315
TABLE 277 INTUITIVE SURGICAL, INC.: DEALS (JANUARY 2020–DECEMBER 2023) 315
11.2.2 KARL STORZ 316
TABLE 278 KARL STORZ: COMPANY OVERVIEW (2022) 316
TABLE 279 KARL STORZ: PRODUCTS OFFERED 316
TABLE 280 KARL STORZ: DEALS (JANUARY 2020–DECEMBER 2023) 318
TABLE 281 KARL STORZ: EXPANSIONS (JANUARY 2020–DECEMBER 2023) 318
11.2.3 EDWARDS LIFESCIENCES CORPORATION 319
TABLE 282 EDWARDS LIFESCIENCES CORPORATION: COMPANY OVERVIEW 319
FIGURE 59 EDWARDS LIFESCIENCES CORPORATION: COMPANY SNAPSHOT (2022) 320
TABLE 283 EDWARDS LIFESCIENCES CORPORATION: PRODUCTS OFFERED 320
11.2.4 SMITH+NEPHEW 321
TABLE 284 SMITH+NEPHEW: COMPANY OVERVIEW 321
FIGURE 60 SMITH+NEPHEW: COMPANY SNAPSHOT (2022) 322
TABLE 285 SMITH+NEPHEW: PRODUCTS OFFERED 322
TABLE 286 SMITH+NEPHEW: PRODUCT LAUNCHES (JANUARY 2020–DECEMBER 2023) 323
TABLE 287 SMITH+ NEPHEW: DEALS (JANUARY 2020–DECEMBER 2023) 324
11.2.5 GE HEALTHCARE 325
TABLE 288 GE HEALTHCARE: COMPANY OVERVIEW 325
FIGURE 61 GENERAL ELECTRIC: COMPANY SNAPSHOT (2022) 326
TABLE 289 GE HEALTHCARE: PRODUCTS OFFERED 326
TABLE 290 GE HEALTHCARE: PRODUCT LAUNCHES (JANUARY 2020–DECEMBER 2023) 327
TABLE 291 GE HEALTHCARE: DEALS (JANUARY 2020–DECEMBER 2023) 327
TABLE 292 NIPRO CORPORATION: COMPANY OVERVIEW 328
FIGURE 62 NIPRO CORPORATION: COMPANY SNAPSHOT (2022) 329
TABLE 293 NIPRO CORPORATION: PRODUCTS OFFERED 329
TABLE 294 NIPRO CORPORATION: EXPANSIONS (JANUARY 2020–DECEMBER 2023) 330
11.2.7 GETINGE AB 331
TABLE 295 GETINGE AB: COMPANY OVERVIEW 331
FIGURE 63 GETINGE AB: COMPANY SNAPSHOT (2022) 332
TABLE 296 GETINGE AB: PRODUCTS OFFERED 332
11.2.8 CONMED CORPORATION 333
TABLE 297 CONMED CORPORATION: COMPANY OVERVIEW 333
FIGURE 64 CONMED CORPORATION: COMPANY SNAPSHOT (2022) 334
TABLE 298 CONMED CORPORATION: PRODUCTS OFFERED 334
TABLE 299 CONMED CORPORATION: DEALS (JANUARY 2020–DECEMBER 2023) 335
11.2.9 TELEFLEX INCORPORATED 336
TABLE 300 TELEFLEX INCORPORATED: COMPANY OVERVIEW 336
FIGURE 65 TELEFLEX INCORPORATED: COMPANY SNAPSHOT (2022) 337
TABLE 301 TELEFLEX INCORPORATED: PRODUCTS OFFERED 337
TABLE 302 TELEFLEX INCORPORATION: PRODUCT LAUNCHES (JANUARY 2020–DECEMBER 2023) 339
11.2.10 ACCURAY 340
TABLE 303 ACCURAY: COMPANY OVERVIEW 340
FIGURE 66 ACCURAY: COMPANY SNAPSHOT (2022) 341
TABLE 304 ACCURAY: PRODUCTS OFFERED 341
TABLE 305 ACCURAY: PRODUCT LAUNCHES (JANUARY 2020–DECEMBER 2023) 342
TABLE 306 ACCURAY: DEALS (JANUARY 2020–DECEMBER 2023) 342
11.2.11 OLYMPUS CORPORATION 343
TABLE 307 OLYMPUS CORPORATION: COMPANY OVERVIEW 343
FIGURE 67 OLYMPUS CORPORATION: COMPANY SNAPSHOT (2022) 344
TABLE 308 OLYMPUS CORPORATION: PRODUCTS OFFERED 344
TABLE 309 OLYMPUS CORPORATION: PRODUCT LAUNCHES & APPROVALS (JANUARY 2020–DECEMBER 2023) 346
TABLE 310 OLYMPUS CORPORATION: DEALS (JANUARY 2020–DECEMBER 2023) 346
*Business Overview, Products/Services/Solutions Offered, MnM View, Key Strengths and Right to Win, Strategic Choices Made, Weaknesses and Competitive Threats, Recent Developments might not be captured in case of unlisted companies.
11.2.12 MASIMO 348
11.2.13 COOPERSURGICAL INC. 348
11.2.14 APPLIED MEDICAL 349
11.2.15 RICHARD WOLF 350
12 APPENDIX 351
12.1 DISCUSSION GUIDE 351
12.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 356
12.3 CUSTOMIZATION OPTIONS 358
12.4 RELATED REPORTS 358
12.5 AUTHOR DETAILS 359
Table of Contents